Bosentan
Brand name: Bosentan
Rank #458 of 500 drugs by total cost
$16.5M
Total Cost
2,765
Total Claims
$16.5M
Total Cost
164
Prescribers
$5,980
Cost per Claim
0
Beneficiaries
2,766
30-Day Fills
$101K
Avg Cost/Provider
17
Avg Claims/Provider
About Bosentan
Bosentan (sold as Bosentan) was prescribed 2,765 times by 164 Medicare Part D providers in 2023, costing the program $16.5M. At $5,980 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 455 | Lanreotide Acetate (Somatuline Depot) | $16.7M | 1,753 |
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology